Download PDF
Ultrasound Int Open 2015; 01(01): E12-E18
DOI: 10.1055/s-0035-1555880
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Accuracy of Contrast-Enhanced Ultrasound in the Diagnosis of Bile Duct Obstruction

F. J. P. Fontán
1   Radiology, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain
,
Á. R. Reboredo
2   Radiology, Complejo Hospitalario Universitario Arquitecto Marcide, A Coruña, Spain
,
A. R. Siso
1   Radiology, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain
› Author Affiliations
Further Information

Publication History

received 03 March 2015

accepted 22 June 2015

Publication Date:
28 July 2015 (online)

   Permissions and Reprints

Abstract

Purpose:

To investigate the ability of contrast-enhanced ultrasound (CEUS) to differentiate benign from malignant lesions causing biliary duct obstruction.

Materials and Methods:

Between November 2006 and December 2013, 59 patients with bile duct obstruction of undetermined cause in baseline ultrasound underwent CEUS study. The enhancement and posterior washout were analyzed in real time all along the study duration (5′). The final diagnosis suggested by CEUS was compared with histologic diagnosis (47.5%) or with radiologic follow-up with TC, RM or ERCP.

Results:

Final diagnoses included 42 malignant lesions (cholangiocarcinoma n=22, metastases n=6, pancreatic carcinoma n=6, hepatocarcinoma n=4, gallbladder carcinoma n=2, ampullary carcinoma n=1 and lymphoma n=1) and 17 benign lesions (lithiasis or biliary sludge n=15, xanthogranulomatous cholecystitis n=1 and indeterminate n=1). CEUS accuracy compared with final diagnoses based on combined reference standard was 86.4%. CEUS correctly identified 36 of 42 malignant lesions (sensibility 85.7%) and 15 of 17 benign lesions (specificity 88.2%). The positive predictive value of CEUS for malignancy was 94.7%, while the negative predictive value was 71.4%.

Conclusion:

CEUS is useful to differentiate between benign and malignant causes of obstructive jaundice. This technique improves the detection of bile duct invasion in hepatic neoplasms and permits better evaluation of intra- and extraductal extension of hilar hepatobiliary tumors.

Key words

abdomen - biliary system - ultrasound
 

  • References

  • 1 Rogoveanu I, Gheonea DI, Saftoiu A et al. The role of imaging methods in identifying the causes of extrahepatic cholestasis. J Gastrointestin Liver Dis 2006; 15: 265-271
    PubMedGoogle Scholar
  • 2 Blackbourne LH, Earnhardt RC, Sistrom CL et al. The sensitivity and role of ultrasound in the evaluation of biliary obstruction. Am Surg 1994; 60: 683-690
    PubMedGoogle Scholar
  • 3 Wilson SR, Burns PN. Microbubble-enhanced US in Body Imaging: What Role?. Radiology 2010; 257: 24-39
    CrossrefPubMedGoogle Scholar
  • 4 Piscaglia F, Bolondi L. The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol 2006; 32: 1369-1375
    CrossrefPubMedGoogle Scholar
  • 5 Claudon M, Dietrich CF, Choi BI et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver – update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med 2013; 34: 11-29
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Piscaglia F, Nolsøe C, Dietrich CF et al. The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med 2012; 33: 33-59
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Xu H-X. Contrast-enhanced ultrasound in the biliary system: Potential uses and indications. World J Radiol 2009; 1: 37-44
    CrossrefPubMedGoogle Scholar
  • 8 Meacock LM, Sellars ME, Sidhu PS. Evaluation of gallbladder and biliary duct disease using microbubble contrast-enhanced ultrasound. Br J Radiol 2010; 83: 615-627
    CrossrefPubMedGoogle Scholar
  • 9 Sparchez Z. Role of contrast enhanced ultrasound in the assessment of biliary duct disease. Med Ultrason 2014; 16: 41-47
    CrossrefPubMedGoogle Scholar
  • 10 Dietrich CF, Cui XW, Boozari B et al. Contrast-enhanced ultrasound (CEUS) in the diagnostic algorithm of hepatocellular and cholangiocellular carcinoma, comments on the AASLD guidelines. Ultraschall Med 2012; 33: S57-S66
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Xu H-X, Chen L-D, Xie X-Y et al. Enhancement pattern of hilar cholangiocarcinoma: contrast-enhanced ultrasound versus contrast-enhanced computed tomography. Eur J Radiol 2010; 75: 197-202
    CrossrefPubMedGoogle Scholar
  • 12 Liu LN, Xu HX, Zheng SG et al. Ultrasound Findings of Intraductal Papillary Neoplasm in Bile Duct and the Added Value of Contrast-Enhanced Ultrasound. Ultraschall Med 2014; DOI: 10.1055/s-0034-1366672.
    PubMedGoogle Scholar
  • 13 Wildner D, Bernatik T, Greis C et al. CEUS in Hepatocellular Carcinoma and Intrahepatic Cholangiocellular Carcinoma in 320 . Patients-Early or Late Washout Matters: A Subanalysis of the DEGUM Multicenter Trial. Ultraschall Med 2015; 36: 132-139
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Fan Z, Li Y, Yan K et al. Application of contrast-enhanced ultrasound in the diagnosis of solid pancreatic lesions – A comparison of conventional ultrasound and contrast-enhanced CT. Eur J Radiol 2013; 82: 1385-1390
    CrossrefPubMedGoogle Scholar